MARKSANSBSEMarksans Pharma LtdMinimalNeutral
Announced Wed, 27 May · 17:56 IST

Newspaper publication of Audited Financial Results for the financial year ended 31 March, 2026

MARKSANS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹248.60
prior close
₹249.55
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.5-1.5-2.2-2.1-2.7-2.7-2.3-3.9-6.1+2.0+4.2+6.2
Up moveDown movePending
AI summary

Marksans Pharma Ltd published newspaper advertisements of its audited financial results for the quarter and year ended March 31, 2026, on May 27, 2026, in Business Standard (English) and Lakshadeep (Marathi) newspapers. The filing was made under SEBI Regulation 47 as part of the company's mandatory disclosure obligations. The full financial results were separately filed with BSE and NSE under Regulation 33 and are available on the company website. The company is listed on BSE (Scrip Code: 524404) and NSE (Symbol: MARKSANS). No specific financial figures or numbers are included in this filing — only confirmation of the newspaper publication.

Likely market impact

This is a routine regulatory compliance filing confirming that the company's audited annual results have been made public through newspaper publication. Shareholders should refer to the full financial results filed separately with the stock exchanges for detailed performance numbers.